Form 4 Cyclacel Pharmaceuticals For: Nov 02 Filed by: MORGAN STANLEY
More News related to CYCC
- Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting
- Cyclacel to Host Conference Call on Monday, December 7 to Discuss New Phase 2 Sapacitabine Data to be Presented at ASH
- Sapacitabine Phase 1 Data Published in Acute Leukemia and Myelodysplastic Syndromes
- NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference
- Cyclacel Pharmaceuticals to Present Sapacitabine Phase 2 AML & MDS Data at the Upcoming American Society of Hematology Meeting
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6583275
Filed on: November 4, 2009
Related Categories
SEC FilingsStocks Mentioned
-0.08
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
